American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

A closer look at GE HealthCare's new lower-cost cardiac CT scanner
As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals.
Cardiologists using less contrast in the cath lab—but there is room to improve
Researchers emphasized that minimizing procedural contrast use is an effective way to reduce the risk of post-PCI acute kidney injury.
Cardiologists make history, use new robotic imaging system for first time
Researchers believe a new robotic TEE system could improve the long-term health of interventional echocardiographers in addition to several other key benefits.
Cardiology employment models undergoing a dramatic shift
Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.
Cardiology groups among the many voices asking Congress not to cut Medicaid
More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health insurance.

Ty Bode, senior director of strategy at GE Healthcare, explains the details of a new, economical cardiac CT scanner GE Healthcare launched at the American College of Cardiology (ACC) 2025 meeting. The Revolution Vibe is designed specifically for coronary CT angiography (CCTA), but at a lower price point than the traditional high-end, flagship scanner that have traditional performed CCTA work.

A closer look at GE HealthCare's new lower-cost cardiac CT scanner

As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals.

Cardiologists using less contrast in the cath lab—but there is room to improve

Researchers emphasized that minimizing procedural contrast use is an effective way to reduce the risk of post-PCI acute kidney injury.

ROB’E Robotic transesophageal echocardiography (TEE)

Cardiologists make history, use new robotic imaging system for first time

Researchers believe a new robotic TEE system could improve the long-term health of interventional echocardiographers in addition to several other key benefits.

Gerald Blackwell, president and CEO of MedAxiom, discusses the business of cardiology at ACC 2025.

Cardiology employment models undergoing a dramatic shift

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.

Cardiology groups among the many voices asking Congress not to cut Medicaid

More than 40 U.S. healthcare organizations are urging Congress not to make sweeping Medicaid cuts that could result in approximately 7.6 million Americans losing health insurance.

Intravascular lithotripsy IVL carotid artery TAVR

A new use for IVL: helping cardiologists secure transcarotid access for TAVR

IVL can do more than help prep patients for PCI. In fact, one heart team used Shockwave Medical's IVL technology to secure access for a high-risk TAVR patient.

Dan Budoff explains use of CCTA to track coronary disease plaque progression

CCTA shows colchicine's impact on atherosclerosis progression

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

Answering key follow-up questions after the FDA approved TAVR in asymptomatic patients

The approval of certain TAVR valves to be used in asymptomatic patients is expected to make a significant impact on patient care going forward.